Soaring dementia treatment costs leave care providers to find solutions: report
By
Alicia Lasek
Nov 02, 2022
The growing needs of patients will put the onus on healthcare providers and other stakeholders to increase access to high-quality dementia care services, the Milken Institute reports.
Study pinpoints risk factors for extreme skin fragility in older adults
By
Alicia Lasek
Dec 21, 2021
More than a quarter of older patients examined in a rehab facility were found to have dermatoporosis, or dangerously fragile skin. Four key factors were associated with higher odds of having the condition,...
Senior care association opens free COVID test kit program to all providers
By
Alicia Lasek
Jan 09, 2023
Industry advocate LeadingAge is now offering free test kits to long-term care providers in all care settings and communities.
Q&A: Clinical best practices when gauging residents’ end-of-life preferences — a POLST expert weighs...
By
Alicia Lasek
Apr 29, 2021
There’s a clear need to improve the quality of Physician’s Orders for Life-Sustaining Treatment, or POLST, in nursing homes, says Susan E. Hickman, Ph.D. An expert on the subject, she spoke with...
Free LTC infection prevention tool from Yale aims to help nursing home staff save time
By
Alicia Lasek
Nov 09, 2021
A one-stop set of infection prevention resources is meant to make work a bit easier for direct care providers, administrators, managers and support staff, say the Yale School of Nursing and the New York...
Residents’ lack of energy may signal malnutrition; full assessment advised
By
Alicia Lasek
Aug 10, 2021
In a study of 13 nursing homes, fully 43% of residents reported that they lacked energy, and 12% were malnourished. The two problems were significantly linked, investigators say.
FDA approves first-ever eye drop that corrects age-related vision loss
By
Alicia Lasek
Nov 02, 2021
The new drug, Vuity, adjusts pupil size and corrects near vision without affecting distance vision, drugmaker Allergan says.
Generic for Viagra holds promise as Alzheimer’s disease treatment, Cleveland Clinic researchers say
Dec 08, 2021
Users of sildenafil are 69% less likely to develop Alzheimer’s disease than their peers who do not use the drug, investigators report. A clinical trial to confirm its benefits for Alzheimer’s patients...
The McKnight’s Tech Awards are back! Recognize an innovation that has changed your game
By
James M. Berklan
May 05, 2021
The deadline is May 25 to highlight a technological innovation — simple or advanced — and show how it has improved care and/or operations in your organization.
FDA OKs new insulin biosimilar for type 2 diabetes
By
Alicia Lasek
Jul 30, 2021
Semglee is a safe and more cost-effective alternative to the drug Lantus (insulin glargine), the agency announced Wednesday. Semglee does not need a prescriber’s input to be substituted at the pharmacy.